182 related articles for article (PubMed ID: 23274456)
1. Pharmacogenetic tests: the need for a level playing field.
Pirmohamed M; Hughes DA
Nat Rev Drug Discov; 2013 Jan; 12(1):3-4. PubMed ID: 23274456
[TBL] [Abstract][Full Text] [Related]
2. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
3. [Significance of genetic tests in the era of personalized medicine].
Molnár JM; Magyarósi S; Németh G
Magy Onkol; 2013 Mar; 57(1):16-20. PubMed ID: 23573517
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
Fabbri C; Zohar J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
[TBL] [Abstract][Full Text] [Related]
5. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
Haga SB; Kantor A
Health Aff (Millwood); 2018 May; 37(5):717-723. PubMed ID: 29733708
[TBL] [Abstract][Full Text] [Related]
6. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine: is it a pharmacogenetic mirage?
Shah RR; Shah DR
Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
[TBL] [Abstract][Full Text] [Related]
8. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
9. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
Drozda K; Müller DJ; Bishop JR
Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic considerations for migraine therapies.
Capi M; Gentile G; Lionetto L; Salerno G; Cipolla F; Curto M; Borro M; Martelletti P
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1161-1167. PubMed ID: 30362834
[TBL] [Abstract][Full Text] [Related]
12. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
Hizel HC
Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
[No Abstract] [Full Text] [Related]
13. Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
Shahin MH; Johnson JA
Curr Opin Cardiol; 2013 May; 28(3):305-14. PubMed ID: 23478884
[TBL] [Abstract][Full Text] [Related]
14. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study.
Herbert D; Neves-Pereira M; Baidya R; Cheema S; Groleau S; Shahmirian A; Tiwari AK; Zai CC; King N; Müller DJ; Kennedy JL
J Psychiatr Res; 2018 Jan; 96():265-272. PubMed ID: 29301639
[TBL] [Abstract][Full Text] [Related]
16. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
[TBL] [Abstract][Full Text] [Related]
17. Clinical implementation of genetic testing in medicine: a US regulatory science perspective.
Lesko LJ; Schmidt S
Br J Clin Pharmacol; 2014 Apr; 77(4):606-11. PubMed ID: 24286486
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling.
Hunt LM; Kreiner MJ
Cult Med Psychiatry; 2013 Mar; 37(1):226-35. PubMed ID: 23264029
[TBL] [Abstract][Full Text] [Related]
19. PARC report: a perspective on the state of clinical pharmacogenomics testing.
Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
[TBL] [Abstract][Full Text] [Related]
20. Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics.
Voskuil MD; Bangma A; Weersma RK; Festen EAM
World J Gastroenterol; 2019 Jun; 25(21):2539-2548. PubMed ID: 31210708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
